The frequency of EGFR, KRAS, HER2 mutations and EML4-ALK fusion were 75.3%, 2%, 5.9% and 5%, separately, in recent analysis of 202 lung adenocarcinoma samples from Chinese patients who never smoked [18]. Here, ERBB2 is linked to lung adenocarcinoma.